Latest Pneumococcal infection Stories
A 10-valent pneumococcal conjugate vaccine (PCV) is effective in reducing the number of new cases of likely-bacterial community-acquired pneumonia in infants in Latin America.
In a study of adults with severe bacterial meningitis, therapeutic hypothermia (reduction of body temperature) did not improve outcomes, and it may even have been harmful.
It is well known that COPD patients run a higher risk of contracting respiratory infections.
Bacterial meningitis is an infection of the meninges, the protective membrane that covers the spinal cord and brain.
The vaccine given to children to immunize against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.
Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail.
Vaccines against the primary cause of deaths from pneumonia in developing countries could save millions of lives and are highly cost-effective.
Vaccinating young children against pneumonia in turn will protect the entire community.
Streptococcus pneumoniae, or pneumococcus, is Gram-positive, alpha-hemolytic, bile-soluble aerotolerant, anaerobic member of the genus Streptococcus. It was recognized as a major cause of pneumonia in the late 19th century and is thus the subject of many humoral immunity studies. It causes many other types of pneumococcal infections other than pneumonia including acute sinusitis, otitis media, meningitis, bacteremia, sepsis, septic arthritis, peritonitis, cellulites, and brain abscess. It...
- A volcanic mudflow.